Journal articleAME Case Rep2025
Adjusted gemcitabine plus S-1 regimen as first‑line chemotherapy in unresectable advanced pancreatic cancer: a long-term survival case report.
- Journal
- AME Case Rep
- Published
- 11 September 2025
- Citations
- 0
- Type
- Article
- License
- cc by-nc-nd
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try